182 related articles for article (PubMed ID: 22333264)
1. Clinical decision support of therapeutic drug monitoring of phenytoin: measured versus adjusted phenytoin plasma concentrations.
Krasowski MD; Penrod LE
BMC Med Inform Decis Mak; 2012 Feb; 12():7. PubMed ID: 22333264
[TBL] [Abstract][Full Text] [Related]
2. Free phenytoin assessment in patients: measured versus calculated blood serum levels.
Tobler A; Hösli R; Mühlebach S; Huber A
Int J Clin Pharm; 2016 Apr; 38(2):303-9. PubMed ID: 26746902
[TBL] [Abstract][Full Text] [Related]
3. Serum albumin-adjusted phenytoin levels: an approach for predicting drug efficacy in patients with epilepsy, suitable for developing countries.
Tandon M; Pandhi P; Garg SK; Prabhakar SK
Int J Clin Pharmacol Ther; 2004 Oct; 42(10):550-5. PubMed ID: 15516024
[TBL] [Abstract][Full Text] [Related]
4. Total phenytoin concentrations do not accurately predict free phenytoin concentrations in critically ill children.
Wolf GK; McClain CD; Zurakowski D; Dodson B; McManus ML
Pediatr Crit Care Med; 2006 Sep; 7(5):434-9; quiz 440. PubMed ID: 16885794
[TBL] [Abstract][Full Text] [Related]
5. Differences between the measured and calculated free serum phenytoin concentrations in epileptic patients.
Hong JM; Choi YC; Kim WJ
Yonsei Med J; 2009 Aug; 50(4):517-20. PubMed ID: 19718399
[TBL] [Abstract][Full Text] [Related]
6. Predicting Unbound Phenytoin Concentrations: Effects of Albumin Concentration and Kidney Dysfunction.
Montgomery MC; Chou JW; McPharlin TO; Baird GS; Anderson GD
Pharmacotherapy; 2019 Jul; 39(7):756-766. PubMed ID: 31067355
[TBL] [Abstract][Full Text] [Related]
7. Correlation of Free and Total Phenytoin Serum Concentrations in Critically Ill Patients.
Buckley MS; Reeves BA; Barletta JF; Bikin DS
Ann Pharmacother; 2016 Apr; 50(4):276-81. PubMed ID: 26783351
[TBL] [Abstract][Full Text] [Related]
8. Plasma total phenytoin: a possibly misleading test in developing countries.
Fedler C; Stewart MJ
Ther Drug Monit; 1999 Apr; 21(2):155-60. PubMed ID: 10217333
[TBL] [Abstract][Full Text] [Related]
9. Predicting unbound phenytoin concentrations in the critically ill neurosurgical patient.
Mlynarek ME; Peterson EL; Zarowitz BJ
Ann Pharmacother; 1996 Mar; 30(3):219-23. PubMed ID: 8833553
[TBL] [Abstract][Full Text] [Related]
10. Estimation of Free Phenytoin Concentration in Critically Ill Patients with Hypoalbuminemia: Direct-measurement vs Traditional Equations.
Wilfred PM; Mathew S; Chacko B; Prabha R; Mathew BS
Indian J Crit Care Med; 2022 Jun; 26(6):682-687. PubMed ID: 35836626
[TBL] [Abstract][Full Text] [Related]
11. Comparisons of Four Protein-Binding Models Characterizing the Pharmacokinetics of Unbound Phenytoin in Adult Patients Using Non-Linear Mixed-Effects Modeling.
Jun H; Rong Y; Yih C; Ho J; Cheng W; Kiang TKL
Drugs R D; 2020 Dec; 20(4):343-358. PubMed ID: 33026608
[TBL] [Abstract][Full Text] [Related]
12. Characterization of unbound phenytoin concentrations in neurointensive care unit patients using a revised Winter-Tozer equation.
Kane SP; Bress AP; Tesoro EP
Ann Pharmacother; 2013 May; 47(5):628-36. PubMed ID: 23606554
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic Drug Monitoring of Phenytoin by Simple, Rapid, Accurate, Highly Sensitive and Novel Method and Its Clinical Applications.
Shaikh AS; Guo R
Curr Pharm Biotechnol; 2017; 18(13):1098-1105. PubMed ID: 29437004
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic drug monitoring of antiepileptic drugs.
Shakya G; Malla S; Shakya KN; Shrestha R
JNMA J Nepal Med Assoc; 2008; 47(171):94-7. PubMed ID: 19079370
[TBL] [Abstract][Full Text] [Related]
15. Estimating phenytoin concentrations by the Sheiner-Tozer method in adults with pronounced hypoalbuminemia.
Dager WE; Inciardi JF; Howe TL
Ann Pharmacother; 1995; 29(7-8):667-70. PubMed ID: 8520077
[TBL] [Abstract][Full Text] [Related]
16. Nonlinear protein binding of phenytoin in clinical practice: Development and validation of a mechanistic prediction model.
Ter Heine R; Kane SP; Huitema ADR; Krasowski MD; van Maarseveen EM
Br J Clin Pharmacol; 2019 Oct; 85(10):2360-2368. PubMed ID: 31269540
[TBL] [Abstract][Full Text] [Related]
17. Clinical evaluation of plasma free phenytoin measurement and factors influencing its protein binding.
Iwamoto T; Kagawa Y; Naito Y; Kuzuhara S; Okuda M
Biopharm Drug Dispos; 2006 Mar; 27(2):77-84. PubMed ID: 16308884
[TBL] [Abstract][Full Text] [Related]
18. Free phenytoin concentration measurement in brain extracellular fluid: a pilot study.
Tisdall M; Russo S; Sen J; Belli A; Ratnaraj N; Patsalos P; Petzold A; Kitchen N; Smith M
Br J Neurosurg; 2006 Oct; 20(5):285-9. PubMed ID: 17129875
[TBL] [Abstract][Full Text] [Related]
19. A Comprehensive Review on the Predictive Performance of the Sheiner-Tozer and Derivative Equations for the Correction of Phenytoin Concentrations.
Kiang TK; Ensom MH
Ann Pharmacother; 2016 Apr; 50(4):311-25. PubMed ID: 26825643
[TBL] [Abstract][Full Text] [Related]
20. Revised Winter-Tozer equation for normalized phenytoin concentrations in trauma and elderly patients with hypoalbuminemia.
Anderson GD; Pak C; Doane KW; Griffy KG; Temkin NR; Wilensky AJ; Winn HR
Ann Pharmacother; 1997 Mar; 31(3):279-84. PubMed ID: 9066931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
